Under the proposed deal, the PE firm would take a controlling 50% stake in Sanofi’s Opella unit, with state-owned Bpifrance taking a minority 2% position.

Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French ...

A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...

Sanofi and private equity firm CD&R are in negotiations to sell a 50% stake in Opella, Sanofi's consumer healthcare division. With a €16B valuation, Opella is the third-largest player in the global ...

Sanofi announced on Monday that it had entered into exclusive negotiations with US investment fund CD&R to sell it a majority ...

European financial services sector specialist BlackFin Capital Partners has closed its fourth fund at €1.8 billion, beating its initial €1.5 billion ($1.96bn) target.

By Dominique Patton PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% ...

CD&R is nearing a deal to acquire control of Sanofi’s consumer health unit after it signed social commitments with the French ...

French pharmaceutical company Sanofi has entered exclusive talks to sell a 50% stake in its consumer health business Opella ...

PARIS (Reuters) -Sanofi said on Monday it had entered exclusive talks for the sale of a 50% controlling stake in its consumer ...

The sale of a French drugmaker to an American group is likely to now go ahead after French Economy Minister Antoine Armand said on Sunday that he had received "guarantees".

Clayton Dubilier & Rice is nearing a deal to acquire control of Sanofi’s consumer health unit after the American buyout firm ...